Pharmaceutical PV DIV - FSB

The Defense Logistics Agency awarded a $32,725.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, represents one of numerous purchase orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The contract was awarded without set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is positioned as a critical regional pharmaceutical supplier within the $30.3 billion PPV-G GEN V acquisition strategy, authorized to provide firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support Department of Defense military healthcare facilities worldwide.

DMS Pharmaceutical Group's established performance across its comprehensive product portfolio—including specialty pharmaceuticals such as oncology treatments, immunosuppressants, biologics, emergency medications, and routine pharmaceuticals—demonstrates its capability to fulfill diverse and specialized pharmaceutical requirements of the federal military medical system. The company's underlying Indefinite Delivery Contract under PPV-G GEN V carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. With no identified subcontractor relationships and a demonstrated track record of substantial federal contracting activity since its System for Award Management registration in July 2001, DMS Pharmaceutical Group serves as a primary pharmaceutical supplier supporting recurring medical supply needs across the Department of Defense healthcare enterprise.